We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biotech Co. Wants Investors' Stock-Drop Suit Tossed

Law360, New York (November 13, 2017, 9:02 PM EST) -- ImmunoCellular Therapeutics Ltd. urged a California federal court on Friday to toss a proposed class action accusing the biotech company of an illegal stock promotion scheme around one of its brain cancer drug candidates, arguing that the alleged scheme’s disclosure came too late to have caused the losses claimed by the investors behind the suit.

ImmunoCellular told the court that these investors have admitted the first disclosure “even hinting at” the alleged promotional activity came in the form of the company’s March 2016 announcement of its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.